… A research team from Thomas Jefferson University recently … important to note: These results are still very much in the early stages of clinical research.  The team, led by … a naturally occurring substance called GM1 ganglioside into the brain.  Researchers think that GM1 may be reduced …

… reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and … therapies outside of trials. What to know about both research and clinics. Learn more Save for later News in … Pipeline Remains Strong February 10, 2021 Two drugs in early studies attempting to treat Parkinson’s disease in …

… needed and the clinical effects of the treatment, but the early data is promising. Levodopa Limitations and Gene … The brain uses the enzyme AADC to convert levodopa into dopamine, the chemical messenger that helps control … the treatment. With imaging tools (MRI and PET scans), the researchers could see good results in getting the drug to …

… About Us:  The Michael J. Fox Foundation for Parkinson’s Research (MJFF) was founded in 2000 with a single defined … triple-pronged, singularly-defined strategy towards disease research enables a dynamic, motivated, and young organization. MJFF has quickly grown into the largest global funder of Parkinson’s disease …

… significantly. ( Read more about cognitive changes in PD. ) Researchers and doctors are currently unable to definitively … (objective measures) of cognitive changes and decline in early Parkinson's disease. The investigators, led by Daniel … and longer-term studies, but they give us a window into how and why cognitive problems develop in PD, and who …